| Sur un cas d'agrypnie (4 mois sans sommeil) au cours d'une maladie de Morvan. Effet favorable du 5-hydroxytryptophane |
| C. Fischer-Perroudon, J. Mouret et M. Jouvet Electroencephalography and Clinical Neurophysiology, 1974, 36: 1-18 |
| IMPRESSION |
| Version imprimable (Tout l'article dans une seule page) |
Figure 5 : Cumulative histogram of the duration of sleep (in minutes) every 10 min, for 16 consecutive nights
The arrows represent the time of the ingestion of a large dose of DL-5-HTP (5 g per diem) (at 23 p.m. and 4 a.m.).
Dotted line: Stages II, III and IV.
Continuous line: Paradoxical sleep.
Interrupted line: Sleep (II, III, IV) under placebos given at the same time when 5-HTP is usually given (16 nights).